Meraz IM - Search Results

1

Correction: Multivalent Presentation of MPL by Porous Silicon Microparticles Favors T Helper 1 Polarization Enhancing the Anti-Tumor Efficacy of Doxorubicin Nanoliposomes.

Meraz IM, Hearnden CH, Liu X, Yang M, Williams L, Savage DJ, Gu J, Rhudy JR, Yokoi K, Lavelle EC, Serda RE. Meraz IM, et al. PLoS One. 2024 Nov 21;19(11):e0314577. doi: 10.1371/journal.pone.0314577. eCollection 2024. PLoS One. 2024. PMID: 39570970 Free PMC article.

2

SMARCA4 mutation induces tumor cell-intrinsic defects in enhancer landscape and resistance to immunotherapy.

Wang Y, Meraz IM, Qudratullah M, Kotagiri S, Han Y, Xi Y, Wang J, Lissanu Y. Wang Y, et al. Among authors: meraz im. bioRxiv [Preprint]. 2024 Jun 22:2024.06.18.599431. doi: 10.1101/2024.06.18.599431. bioRxiv. 2024. PMID: 38948751 Free PMC article. Preprint.

3

Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer.

Haderk F, Chou YT, Cech L, Fernández-Méndez C, Yu J, Olivas V, Meraz IM, Barbosa Rabago D, Kerr DL, Gomez C, Allegakoen DV, Guan J, Shah KN, Herrington KA, Gbenedio OM, Nanjo S, Majidi M, Tamaki W, Pourmoghadam YK, Rotow JK, McCoach CE, Riess JW, Gutkind JS, Tang TT, Post L, Huang B, Santisteban P, Goodarzi H, Bandyopadhyay S, Kuo CJ, Roose JP, Wu W, Blakely CM, Roth JA, Bivona TG. Haderk F, et al. Among authors: meraz im. Nat Commun. 2024 May 3;15(1):3741. doi: 10.1038/s41467-024-47423-0. Nat Commun. 2024. PMID: 38702301 Free PMC article.

4

Author Correction: 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib.

Meraz IM, Majidi M, Fang B, Meng F, Gao L, Shao R, Song R, Li F, Lissanu Y, Chen H, Ha MJ, Wang Q, Wang J, Shpall E, Jung SY, Haderk F, Gui P, Riess JW, Olivas V, Bivona TG, Roth JA. Meraz IM, et al. Commun Biol. 2023 Jun 6;6(1):608. doi: 10.1038/s42003-023-04979-9. Commun Biol. 2023. PMID: 37280434 Free PMC article. No abstract available.

5

3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib.

Meraz IM, Majidi M, Fang B, Meng F, Gao L, Shao R, Song R, Li F, Lissanu Y, Chen H, Ha MJ, Wang Q, Wang J, Shpall E, Jung SY, Haderk F, Gui P, Riess JW, Olivas V, Bivona TG, Roth JA. Meraz IM, et al. Commun Biol. 2023 May 11;6(1):509. doi: 10.1038/s42003-023-04889-w. Commun Biol. 2023. PMID: 37169941 Free PMC article.

6

TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanized mouse model.

Meraz IM, Majidi M, Shao R, Meng F, Ha MJ, Shpall E, Roth JA. Meraz IM, et al. Commun Biol. 2022 Feb 24;5(1):167. doi: 10.1038/s42003-022-03103-7. Commun Biol. 2022. PMID: 35210547 Free PMC article.

7

An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses.

Meraz IM, Majidi M, Meng F, Shao R, Ha MJ, Neri S, Fang B, Lin SH, Tinkey PT, Shpall EJ, Morris J, Roth JA. Meraz IM, et al. Cancer Immunol Res. 2019 Aug;7(8):1267-1279. doi: 10.1158/2326-6066.CIR-18-0874. Epub 2019 Jun 11. Cancer Immunol Res. 2019. PMID: 31186248 Free PMC article.

8

Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer.

Pu X, Zhang R, Wang L, Chen Y, Xu Y, Pataer A, Meraz IM, Zhang X, Wu S, Wu L, Su D, Mao W, Heymach JV, Roth JA, Swisher SG, Fang B. Pu X, et al. Among authors: meraz im. J Transl Med. 2018 Nov 26;16(1):328. doi: 10.1186/s12967-018-1704-3. J Transl Med. 2018. PMID: 30477533 Free PMC article.

9

TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models.

Meraz IM, Majidi M, Cao X, Lin H, Li L, Wang J, Baladandayuthapani V, Rice D, Sepesi B, Ji L, Roth JA. Meraz IM, et al. Cancer Immunol Res. 2018 Feb;6(2):163-177. doi: 10.1158/2326-6066.CIR-17-0273. Epub 2018 Jan 16. Cancer Immunol Res. 2018. PMID: 29339375 Free PMC article.

10

Overcoming resistance to anti-PD immunotherapy in a syngeneic mouse lung cancer model using locoregional virotherapy.

Yan X, Wang L, Zhang R, Pu X, Wu S, Yu L, Meraz IM, Zhang X, Wang JF, Gibbons DL, Mehran RJ, Swisher SG, Roth JA, Fang B. Yan X, et al. Among authors: meraz im. Oncoimmunology. 2017 Oct 31;7(1):e1376156. doi: 10.1080/2162402X.2017.1376156. eCollection 2017. Oncoimmunology. 2017. PMID: 29296537 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters